跳至主要内容
临床试验/NL-OMON51854
NL-OMON51854尚未招募不适用

on-invasive preimplantation genetic testing (niPGT) - haplotyping by sequencing embryo spent culture medium - non-invasive preimplantation genetic testing (niPGT)

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 317 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
317

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Group inclusion criteria:
  • To be eligible to participate in this study, a couple must meet all of the
  • following criteria:
  • Couples that have or are carrier of a known severe genetic disorder that choose
  • to do in vitro fertilization (IVF) following preimplantation genetic testing
  • (PGT-IVF). Inclusion criteria of couples are similar to inclusion criteria from
  • PGT that are the following:
  • o The offspring have a high risk on inheriting a severe genetic disorder (as
  • nationally determined by national indication committee); PGT-M.
  • o There is a high risk of miscarriage due to an unbalanced translocation or a
  • high risk of an ongoing pregnancy of a child with an unbalanced translocation
  • Couples meet the requirements for IVF.
  • The comprehensive, sequencing-based haplotyping analysis will be used for
  • analysis of PGT-M
  • The VeriSeq PGS analysis method is used for PGT-SR.
  • Sample inclusion criteria:
  • Oocytes are successfully fertilized and develop into d3 embryos or
  • blastocysts (d5/6/7 embryos).
  • Embryos are successfully biopsied and the conventional PGT result is
  • conclusive.
  • Spent culture medium samples from the PGT-IVF embryos could be collected and

排除标准

  • Group exclusion criteria:
  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study.
  • Couples unable to give informed consent to any of the study aspects or unable
  • to comply with the protocol
  • o When participants are < 18 years
  • o Couples that do not speak Dutch will be excluded from participation in this
  • IVF/PGD treatment for a mitochondrial disorder (linked to mtDNA).
  • The analysis of the embryos is done using a day 3 biopsy and subsequent
  • fluorescence in situ hybridization (FISH) analysis.
  • The analysis of the embryo is done using the PCR-based STR marker analysis
  • It is technically not possible to test the preimplantation embryo for the
  • genetic disorder, as determined by the preparation tests for PGT.
  • Sample exclusion criteria:
  • A potential sample who meets any of the following criteria will be excluded
  • from participation in this study.
  • A specific sample will be excluded for analysis when not enough (< 10 µl) or
  • no spent culture medium of the embryo could be collected. In case of no spent
  • culture medium, the other SCM samples from the same PGT couple will still be

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验